Ozempic 2 - Search News

Novo Nordisk’s Ozempic Gets FDA Approval

CNN on MSN · 10h

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Forbes on MSN · 11h

Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and strokes.

The New York Times · 10h

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

9h

Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

5don MSN

Ozempic’s health benefits keep growing, but are the risks worth it?

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

4don MSN

Sweeping New Study Confirms Serious Ozempic Side Effects: What A Doctor Wants You To Know

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results